Supportive infusions & selected therapies
Support chosen for a defined clinical indication.
Some patients need supportive treatment alongside cancer care, or for a separate documented indication. A treating clinician must decide whether a specific infusion is appropriate. This page is a service directory, not a menu for self-prescribing.
Selected supportive therapies that may be considered
IV iron
May be considered for an appropriate iron-deficiency indication after clinical and laboratory assessment, not as universal prophylaxis.
Hydration
May be prescribed for a defined clinical reason. Fluid, amount, rate and monitoring depend on the clinician’s assessment.
Electrolyte replacement
Requires a documented indication, appropriate assessment and monitoring.
Antiemetic and symptom relief
May be used when prescribed as part of symptom management or a treatment-specific supportive plan.
Selected bone-modifying therapies
Therapies such as zoledronic acid, only where indicated, prescribed and supported by pre-assessment and facility protocol.
Other selected treatments
Added to the live list only after clinical indications, staff competency, supply, protocols and site availability are confirmed.
Treatment-specific prophylaxis and risk reduction
For selected regimens or individual clinical risks, the responsible clinician may prescribe measures intended to reduce a defined treatment-related complication. The agent, route, timing and monitoring come from the current protocol and the clinician’s order.
- Premedication and reaction-risk management: only for the medicine and situation for which the protocol indicates it.
- Antiemetic support: before or during a prescribed treatment, where the regimen and plan call for it.
- Hydration and electrolyte support: part of selected protocols, or for a documented indication.
- Other pharmacological prophylaxis: some risk-reducing medicines are tablets or injections, not infusions.
- High-risk sessions: the plan specifies whether additional observation, trained staff or a higher-acuity setting is needed.
Supportive prevention is not cancer prevention
Certain prescribed supportive measures may reduce a defined treatment-related risk for selected regimens or patients. They are not universal “prevention infusions”. KPCIRC does not offer a general cancer-prevention infusion, does not suggest that an infusion prevents a person from developing cancer, and does not suggest that all high-risk patients need prophylactic infusions.
Before an infusion can be arranged
- A prescribed or clinician-approved indication and a documented treatment plan.
- Review of medical history, allergies, current medicines and prior infusion reactions as the protocol requires.
- Confirmation of the exact medicine, dose, route, administration time, monitoring and observation.
- Confirmation that the site has the right staff, equipment, medicines and escalation capability.
- Clear written instructions, fees, billing boundaries and follow-up arrangements.
Frequently asked questions
Can I book an infusion without a prescription?
No. This is not a walk-in or self-selected service. Clinical assessment and a prescription or authorisation are confirmed before any therapy is scheduled.
Are supportive infusions a cancer-prevention treatment?
No. No universal infusion prevents cancer. Some supportive measures may be prescribed for a specific indication or treatment-related risk, based on a clinician’s assessment and the applicable protocol.
Can every infusion be provided at every site?
No. Availability depends on the site, medicines, qualified personnel, equipment, observation capacity and approved procedures.
How are medicines billed?
Prescribed medicines may be billed separately from chair or administration charges. The billing policy is confirmed for each site before booking.
Short explainers, in production
- Treatment-specific prophylaxis and high-risk observationAbout 60–75 seconds